Associate Professor Jessica Howell
Co-head, Hepatitis B and Liver Cancer; Senior Research Fellow
Working groups
Background
Jessica is consultant gastroenterologist at St Vincent's Hospital and The Royal Melbourne Hospital, with a research interest in liver cancer and viral hepatitis.
She completed my PhD exploring the role of the innate immune system in hepatitis C disease post liver transplantation. She received an NHMRC Sidney Sax Early Career Research Fellowship for post-doctoral studies at Imperial College London (Department of Hepatology), where she worked with a team on public health projects targeting reduction of HBV-related liver disease and liver cancer in Sub-saharan Africa and exploring genetic mutation analysis of circulating free tumour DNA in liver cancer in collaboration with Cologne University (Germany).
Jessica is currently working on further projects exploring genetics of liver cancer and the epidemiology of liver disease and liver cancer under the mentorship of Professor Margaret Hellard. She is involved in hepatology training and public health projects in Fiji.
Qualifications
- MBBS (Hons)
- PhD (Medicine)
- FRACP - Gastroenterology
Appointments
- Alfred Human Research Ethics Committee (HREC), Alfred Health
- CR Roper Senior Research Fellow, Department of Medicine, University of Melbourne
- Adjunct Senior Research Fellow, Epidemiology and Disease Prevention, Monash University
- Postdoctoral Fellow, Department of Medicine, University of Melbourne
- Honorary Postdoctoral Fellow, Imperial College London, UK
- FRACP
- Masters student, London School of Hygiene and Tropical Medicine (MSc Epi, Post Grad Dip Public Health)
Awards
- 2022 Inaugural Tony Burgess Medal. VCCC Alliance
- 2013 NHMRC Early Career Research Fellowship Bushell/ GESA Post Doctoral Research Scholarship
- 2012 RACP CRB Bushell Scholarship Astra-Zeneca/ GESA Grant-In-Aid Scholarship Young Investigator Bursary, European Association for the Study of the Liver.
- 2011 GESA Frenesius Kabi Travel Bursary
- 2009 GESA (Gastroenterology Society of Australia) Clinical Research Scholarship (PhD)
- 1998 National Heart Foundation Summer Scholarship
- 1999 Anti-Cancer Council Summer Research Scholarship
- 2002 MBBS with First Class Honours Deans Honour’s List Jamieson Prize for best student in Clinical Medicine; Tom Keen Prize for best student in Chemical Pathology
- 2001 Deans Honour’s List
- 2000 Deans Honour’s List
- 1998 Deans Honour’s List Novartis Prize for best student in Behavioural Science
Positions
- Gastroenterologist and hepatologist, St Vincent’s Hospital Melbourne
- Fellow of the Royal Australasian College of Physicians
- Committee member of the Australian Liver Association (ALA), Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) and Gastroenterological Society of Australia (GESA)
Burnet publications
View 67 moreKnowledge and Perceptions of Hepatitis B in Immigrant Populations: A Systematic Review and Thematic Synthesis of Qualitative Research
Journal of Viral Hepatitis
Marvad Ahad et al
Age, period and cohort trends in hospital admissions for alcohol‐related liver disease in Australia, 1993–2020
Drug and Alcohol Review
Michael Livingston et al
Synthesising enablers and barriers to hepatocellular carcinoma surveillance—A systematic review of qualitative findings
PLoS ONE
Dina Moussa et al
Current projects
View 9 moreLiver health screening test
A rapid point-of-care (POC) test for liver disease biomarkers could improve the management of acute and chronic liver disease and reduce the progression to liver cancer in Australia and globally.
Public health interventions to achieve hepatitis B elimination and reduce liver cancer
Our research projects aim to address the key goals of the World Health Organization global hepatitis B elimination program.
Eliminate Hepatitis C Australia (EC Australia)
Partnering to eliminate hepatitis C as a public health threat by 2030.
Past projects
View 4 moreThe OCP HCC Study: liver cancer optimal care pathway
We explore whether liver cancer care is provided in Australia in accordance with official guidelines.
Rapid-EC hepatitis C Pilot Study
The introduction of direct-acting antiviral (DAA) therapies has meant the elimination of hepatitis C as a public health issue in Australia is a very real possibility. The challenge that remains is to ensure that all people living with HCV can access testing to become aware of their status and then get treated and cured.
The elimination of hepatitis C as a global public health threat
This project addresses critical knowledge gaps in Australian and global efforts to eliminate hepatitis C as a public health threat by 2030.
News and features
View 1 more
2023 in Review July - December
NHMRC grants for Burnet hepatitis B and STI research
Burnet projects aimed at reducing the burden of hepatitis B in Australia and STIs will be supported by NHMRC Investigator Grants.
New treatment pathways for hepatitis C
Newly published Burnet study demonstrates the feasibility and effectiveness of simplified treatment of hepatitis C in Myanmar.